HF
CMND icon

HRT Financial’s Clearmind Medicine CMND Stock Holding History

HRT Financial’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77K Buy
4,393
+4,194
+2,108% +$191K ﹤0.01% 3677
2026
Q1 		$16K Buy
+199
New +$24.6K ﹤0.01% 3592
2024
Q4 		– Sell
-4
Closed -$15K – 2526
2024
Q3 		$15K Buy
+4
New +$18.2K ﹤0.01% 2209
2023
Q3 		– Hold
0
– -$8K – 2472
2023
Q2 		– Hold
0
– – – 2186

Other funds holding CMND

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's CMND Position: Q2 2026 in Review

HRT Financial increased its Clearmind Medicine (CMND) stake by 2,108% in Q2 2026, buying an estimated $191K and bringing the position to 4,393 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

HRT Financial first reported a position in CMND in Q3 2024 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

  • HRT Financial held 4,393 shares of Clearmind Medicine worth $77K as of Q2 2026.
  • HRT Financial bought 4,194 Clearmind Medicine shares in Q2 2026, an estimated $191K.
  • Clearmind Medicine made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3677 holding.
  • HRT Financial first reported a position in Clearmind Medicine in Q3 2024 and has held it in 3 quarters since.
  • 5 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.